Related Experiment Videos
[Depressive disorders in leukemia]
Marcin Jabłoński1, Halina Lebiedowicz, Dominika Dudek
1Katedry i Kliniki Psychiatrii CM UJ. marcinjablonski@interia.pl
Psychiatria Polska
|November 25, 2003
Summary
Depression may worsen outcomes for cancer patients, particularly those with hematological malignancies. This review explores the link between mood and survival in these patients.
Area of Science:
- Oncology
- Hematology
- Psychiatry
Context:
- Cancer patients often experience depressive symptoms.
- Hematological malignancies present unique challenges.
- Psychosocial factors significantly impact cancer care.
Purpose:
- To review the association between depressive symptoms and prognosis in cancer patients.
- To explore the link between depressed mood and outcomes in hematological malignancies.
- To identify factors influencing mood in leukemia patients undergoing treatment.
Summary:
- This paper reviews research on the connection between depression and poor cancer prognosis.
- It specifically examines the potential association between depressed mood and survival in hematological malignancies.
- The review covers acute leukemia, treatments, and psychosocial challenges during diagnosis, chemotherapy, and bone marrow transplantation.
Impact:
- Highlights the importance of mental health in cancer patient care.
- Suggests avenues for improving psychosocial support for hematological malignancy patients.
- Informs clinical practice regarding the management of mood disturbances in oncology.